| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 04/24/2003 | WO2003033457A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 04/24/2003 | WO2003033010A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 04/24/2003 | WO2003033002A1 Intracellular calcium concentration increase inhibitors |
| 04/24/2003 | WO2003032987A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032975A1 Modulation of ocular growth and myopia by gaba drugs |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032966A1 Compositions for potentiating glutatthione |
| 04/24/2003 | WO2003032921A2 Treatment of neurodegenerative diseases and cancer of the brain |
| 04/24/2003 | WO2003032920A2 Oligonucleotide modulation of cell adhesion |
| 04/24/2003 | WO2003032918A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 04/24/2003 | WO2003032916A2 Organosulfur inhibitors of tyrosine phosphatases |
| 04/24/2003 | WO2002100437A3 Ophthalmic compositions comprising hyaluronic acid |
| 04/24/2003 | WO2002068406A3 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 04/24/2003 | WO2002064748A8 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 04/24/2003 | WO2002026825A3 G-protein coupled receptors |
| 04/24/2003 | US20030078289 Indole carboxylic acids as thyroid receptor ligands |
| 04/24/2003 | US20030078274 Method of reducing neuronal injury or apoptosis |
| 04/24/2003 | US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 04/24/2003 | US20030078261 Prostaglandin agonists |
| 04/24/2003 | US20030078258 Adrenergic blocking agents |
| 04/24/2003 | US20030078212 Pharmaceutical compositions containing poly(adp-ribose) glycohydrolase inhibitors and methods of using the same |
| 04/24/2003 | US20030077734 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof |
| 04/24/2003 | US20030077638 MID 4460, a human tyrosine phosphatase family member and uses therefor |
| 04/24/2003 | US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection |
| 04/24/2003 | US20030077571 Model for use in evaluation and treatment of muscular disorders and asthenopia |
| 04/24/2003 | US20030077565 Preservation of corneal graft in vitro; obtain graft, incubate with antisense oligonucleotides in solution, monitor viability of graft tissue |
| 04/24/2003 | US20030077302 An ophthalmic formulation for glaucoma treatment in the form of a suspension gel containing the free acid of diclofenamide, preservatives, gel forming agent and agents to adjust the pH |
| 04/24/2003 | US20030077246 TNFr/OPG-like molecules and uses thereof |
| 04/24/2003 | CA2727642A1 Synthesis of cyclosporin analogs |
| 04/24/2003 | CA2466800A1 Modulation of ocular growth and myopia by gaba drugs |
| 04/24/2003 | CA2463908A1 Human glucagon-like-peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 04/24/2003 | CA2463729A1 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 04/24/2003 | CA2463724A1 Organosulfur inhibitors of tyrosine phosphatases |
| 04/24/2003 | CA2463159A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/24/2003 | CA2460685A1 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 04/23/2003 | EP1304119A2 Method for preventing and treating hearing loss using a neurturin protein product |
| 04/23/2003 | EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/23/2003 | EP1303625A2 Alpha-msh related compounds and methods of use |
| 04/23/2003 | EP1303619A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction |
| 04/23/2003 | EP1303612A2 Streptococcus antigens |
| 04/23/2003 | EP1303527A1 Matrix metalloproteinase inhibitors |
| 04/23/2003 | EP1303522A2 Biologically active macrolides, compositions, and uses thereof |
| 04/23/2003 | EP1303521A1 Tetrahydro-heterocycloazepinyl pyrimidine derivatives |
| 04/23/2003 | EP1303517A1 Indoloquinazolinones |
| 04/23/2003 | EP1303507A1 Pyrimidine derivatives |
| 04/23/2003 | EP1303501A1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 04/23/2003 | EP1303499A1 Tetrazole derivatives |
| 04/23/2003 | EP1303496A1 Pyrimidine derivatives |
| 04/23/2003 | EP1303490A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives |
| 04/23/2003 | EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 04/23/2003 | EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme |
| 04/23/2003 | EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same |
| 04/23/2003 | EP1303304A2 Pharmaceutical combinations for treatment and prevention of diabetes mellitus |
| 04/23/2003 | EP1303286A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals |
| 04/23/2003 | EP1303279A1 Method of treating peripheral vascular diseases, peripheral neuropathies, and autonomic neuropathies |
| 04/23/2003 | EP1303271A1 Ophthalmic formulation of a selective cyclooxygenase-2 inhibitory drug |
| 04/23/2003 | EP1222183B1 Benzopyran derivatives |
| 04/23/2003 | EP1133483B1 Il-5 inhibiting 6-azauracil derivatives |
| 04/23/2003 | EP1114046B1 Interleukin-5 inhibiting 6-azauracil derivatives |
| 04/23/2003 | EP1102739B1 Glucocorticoid and thyroid hormone receptor ligands for the treatment of metabolic disorders |
| 04/23/2003 | EP1094807B1 Vitamin e and esters thereof for use in the topical treatment of mucosal pathologies |
| 04/23/2003 | EP1047406B1 Autoclavable pharmaceutical compositions containing a chelating agent |
| 04/23/2003 | EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels |
| 04/23/2003 | CN1413213A Azaindoles |
| 04/23/2003 | CN1413207A 5-membered ring heterocyclic compounds with nitrogen |
| 04/23/2003 | CN1413193A Nitrile derivatives as cathepsin K inhibitors |
| 04/23/2003 | CN1413192A Substituted indole mannich bases |
| 04/23/2003 | CN1413185A Substitued 1 and 2 naphthol mannich bases |
| 04/23/2003 | CN1413114A System for stabilizing lacrimal fluid layer |
| 04/23/2003 | CN1413107A Use of hypoglycemic agent for treating impaired clucose metabolism |
| 04/23/2003 | CN1413105A Novel method of treatment |
| 04/23/2003 | CN1411823A Medicine for curing myopia and amblyopia and its preparation method |
| 04/23/2003 | CN1411815A Baicalin eye drops and its preparation method |
| 04/23/2003 | CN1411814A Eye lotion |
| 04/23/2003 | CN1411809A Usage and composition of pyridine onium derivative for curing application |
| 04/23/2003 | CN1411800A Cosmetic composition and method |
| 04/23/2003 | CN1106384C Indoline-2-one derivatives, its preparing method and its medicinal compositions |
| 04/22/2003 | US6552202 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide |
| 04/22/2003 | US6552047 H2 receptor antagonist compounds in combination with nitric oxide donors, compositions and methods of use |
| 04/22/2003 | US6552020 Compositions including antibiotics and methods for using same |
| 04/22/2003 | US6552015 Azabicycloalkane derivatives and therapeutic uses thereof |
| 04/22/2003 | US6551590 Preferred hyaluronidase enzyme is devoid of molecular weight fractions below 40,000 MW, between 60-70,000 MW and above 100,OOO MW |
| 04/22/2003 | US6551584 Topical antibiotic composition for treatment of eye infection |
| 04/22/2003 | US6551575 Methods for identifying compounds for motion sickness, vertigo and other disorders related to balance and the perception of gravity |
| 04/22/2003 | CA2281580C Quinoxalinediones |
| 04/22/2003 | CA2253869C Substituted oxobutyric acids as matrix metalloprotease inhibitors |
| 04/19/2003 | CA2361863A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications |
| 04/17/2003 | WO2003031939A2 Protein modification and maintenance molecules |
| 04/17/2003 | WO2003031466A2 Angiotensin peptide-carrier conjugates and uses thereof |
| 04/17/2003 | WO2003031447A2 Pyrimidine derivatives |
| 04/17/2003 | WO2003031440A1 3,4-di-substituted maleimide compounds as cxc-chemokine receptor antagonists |
| 04/17/2003 | WO2003031434A1 Compounds and methods |
| 04/17/2003 | WO2003031407A2 β-LACTAMYL VASOPRESSIN VlaANTAGONISTS |
| 04/17/2003 | WO2003030993A1 2-amino-6-(2,4,5-substituted-phenyl)-pyridines for use as nitric oxide synthase inhibitors |
| 04/17/2003 | WO2003030947A2 Concentrated x-ray contrast media can act as universal antigens and can inhibit or prevent allergic reactions |
| 04/17/2003 | WO2003030941A1 Controlled release drug delivery composition comprising polycationic polymer and negatively charged pharmacologically active compound |
| 04/17/2003 | WO2003030937A1 Remedies for stress diseases comprising mitochondrial benzodiazepine receptor antagonists |
| 04/17/2003 | WO2003030930A1 Human 3 relaxin |